Kala Pharmaceuticals, Inc. (KALA): Price and Financial Metrics
KALA Price/Volume Stats
| Current price | $6.43 | 52-week high | $10.97 |
| Prev. close | $6.47 | 52-week low | $4.21 |
| Day low | $6.00 | Volume | 39,300 |
| Day high | $6.50 | Avg. volume | 82,984 |
| 50-day MA | $6.05 | Dividend yield | N/A |
| 200-day MA | $6.59 | Market Cap | 29.64M |
KALA Stock Price Chart Interactive Chart >
Kala Pharmaceuticals, Inc. (KALA) Company Bio
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies using its proprietary nanoparticle-based Mucus Penetrating Particles technology. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009. Kala Pharmaceuticals, Inc. was founded in 2009 and is based in Waltham, Massachusetts.
KALA Price Returns
| 1-mo | 16.27% |
| 3-mo | 6.99% |
| 6-mo | -1.25% |
| 1-year | 3.21% |
| 3-year | -92.78% |
| 5-year | -96.87% |
| YTD | -8.14% |
| 2023 | -81.65% |
| 2022 | -36.94% |
| 2021 | -82.15% |
| 2020 | 83.74% |
| 2019 | -24.54% |
Continue Researching KALA
Want to see what other sources are saying about Kala Pharmaceuticals Inc's financials and stock price? Try the links below:Kala Pharmaceuticals Inc (KALA) Stock Price | Nasdaq
Kala Pharmaceuticals Inc (KALA) Stock Quote, History and News - Yahoo Finance
Kala Pharmaceuticals Inc (KALA) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...